Literature DB >> 8763864

The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.

G U Dachs1, I J Stratford.   

Abstract

In this review, reports of the increased expression of selected genes in response to hypoxia have been summarised. The best studied mammalian hypoxia response systems are those of the erythropoietin (Epo) and the vascular endothelial growth factor (VEGF) genes, which will be described in some detail. Other genes discussed here include those encoding growth factors, cytokines, transcription factors, metabolic enzymes and DNA repair enzymes. Short DNA sequences (hypoxia response elements) governing the increased gene expression in response to hypoxia have been discovered in the vicinity of most of these genes. The review will end by analysing the possibility of exploiting tumour hypoxia via the use of hypoxia response elements for gene therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763864      PMCID: PMC2150030     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  77 in total

1.  Brain nitric oxide synthase is a haemoprotein.

Authors:  P Klatt; K Schmidt; B Mayer
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells.

Authors:  D L Stoler; G R Anderson; C A Russo; A M Spina; T A Beerman
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

3.  Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors.

Authors:  D L Gustafson; C A Pritsos
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

4.  Activation of the heat shock transcription factor by hypoxia in normal and tumor cell lines in vivo and in vitro.

Authors:  A J Giaccia; E A Auger; A Koong; D J Terris; A I Minchinton; G M Hahn; J M Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  Heat-induced transcription from RNA polymerases II and III and HSF binding activity are co-ordinately regulated by the products of the heat shock genes.

Authors:  B D Price; S K Calderwood
Journal:  J Cell Physiol       Date:  1992-11       Impact factor: 6.384

6.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

7.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen.

Authors:  K R Laderoute; T D Grant; B J Murphy; R M Sutherland
Journal:  Int J Cancer       Date:  1992-09-30       Impact factor: 7.396

9.  Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.

Authors:  K H Plate; G Breier; C L Farrell; W Risau
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

10.  Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain.

Authors:  N D Klempt; E Sirimanne; A J Gunn; M Klempt; K Singh; C Williams; P D Gluckman
Journal:  Brain Res Mol Brain Res       Date:  1992-03
View more
  13 in total

1.  The radiomimetic enediyne, 20'-deschloro-C-1027 induces inter-strand DNA crosslinks in hypoxic cells and overcomes cytotoxic radioresistance.

Authors:  Terry A Beerman; Loretta S Gawron; Ben Shen; Daniel R Kennedy
Journal:  DNA Repair (Amst)       Date:  2014-06-28

Review 2.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

3.  Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer.

Authors:  George E Theodoropoulos; Andreas C Lazaris; Vasilios E Theodoropoulos; Kalliopi Papatheodosiou; Maria Gazouli; John Bramis; Efstratios Patsouris; Dimitrios Panoussopoulos
Journal:  Int J Colorectal Dis       Date:  2005-07-29       Impact factor: 2.571

4.  Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.

Authors:  Toru Shibata; Amato J Giaccia; J Martin Brown
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

5.  C-1027, a radiomimetic enediyne anticancer drug, preferentially targets hypoxic cells.

Authors:  Terry A Beerman; Loretta S Gawron; Seulkih Shin; Ben Shen; Mary M McHugh
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro.

Authors:  R Skøyum; K Eide; K Berg; E K Rofstad
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase.

Authors:  D L Berge; M De Ridder; V N Verovski; M Y Janssens; C Monsaert; G A Storme
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

8.  Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast.

Authors:  R D Leek; R J Landers; A L Harris; C E Lewis
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.

Authors:  K Sundfør; H Lyng; E K Rofstad
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

10.  NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase.

Authors:  M De Ridder; D L Van den Berge; V N Verovski; C Monsaert; N Wauters; G A Storme
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.